Table of Contents
Pregnancy Screening in Vizag | Scans, Blood Tests & Costs
Modern obstetric care relies heavily on Pregnancy Screening in Vizag to monitor maternal and fetal health. Antenatal screening combines diagnostic ultrasound imaging, genetic biochemistry, maternal blood panels, and specialized fetal medicine evaluations. Rather than waiting for symptoms, structured screening systematically assesses fetal anatomy, chromosomal risk, placental efficiency, and maternal metabolic health throughout pregnancy.
Visakhapatnam (Vizag) has emerged as a premier center for advanced fetal medicine across Coastal Andhra Pradesh. Equipped with High-Definition 3D/4D ultrasound systems, Fetal Medicine Foundation (FMF)-certified sonographers, and accredited genetic testing labs, clinics across Health City (Arilova), MVP Colony, Maharani Peta, and Gajuwaka deliver precise prenatal diagnostic services.
What is Pregnancy Screening?
Pregnancy screening refers to a series of non-invasive tests scheduled at specific gestational intervals. Unlike invasive diagnostic tests (such as Amniocentesis or Chorionic Villus Sampling), screening tests present zero risk to the pregnancy. They determine whether a fetus has an elevated risk for chromosomal variations (such as Trisomy 21 / Down Syndrome) or structural anomalies, guiding families toward timely clinical care.
[Pregnancy Screening Architecture]
│
┌───────────────────────────────────┼───────────────────────────────────┐
▼ ▼ ▼
[Ultrasonography Protocols] [Biochemical & Genetic Screening] [Maternal Health & Metabolism]
• Viability & Dating Scan • First Trimester Double Marker • Complete Blood Count (CBC)
• NT Scan (11 - 13+6 Weeks) • Second Trimester Quadruple Marker • Oral Glucose Tolerance (OGTT)
• Anomaly Scan (18 - 22 Wks) • Cell-Free DNA / NIPT Blood Panel • Thyroid Profile (TSH & FT4)
• Growth & Doppler Scan • Preeclampsia Risk Biomarkers • Preeclampsia Doppler Screen
Trimester-Wise Screening Timeline
Antenatal care follows a clear diagnostic schedule divided across the three trimesters:
PREGNANCY SCREENING ROADMAP
│
┌──────────────────────────────────┼──────────────────────────────────┐
▼ ▼ ▼
[FIRST TRIMESTER] [SECOND TRIMESTER] [THIRD TRIMESTER]
(Weeks 6 to 13+6) (Weeks 14 to 27+6) (Weeks 28 to 40)
• Viability Scan (Wks 6-9) • Anomaly Scan (Wks 18-22) • Growth Scan (Wks 28-32)
• NT Scan + Double Marker • Fetal Echo (Wks 18-24) • Umbilical Doppler (Wks 32+)
• NIPT (From Wk 10 onwards) • Quad Marker (Wks 15-20) • Biophysical Profile (BPP)
• Baseline Maternal Bloods • GDM OGTT Test (Wks 24-28) • NST & Fluid Index (AFI)
Detailed Breakdown of Key Screening Protocols
1. First Trimester Screening Protocols
A. Viability & Dating Scan (Weeks 6 to 9)
- Clinical Purpose: Confirms intra-uterine gestational sac placement, rules out ectopic pregnancy, establishes accurate gestational age via Crown-Rump Length (CRL), identifies multiple gestations (twins/triplets), and records early fetal cardiac activity.
B. First Trimester Combined Screening (Weeks 11.0 to 13.6)
This protocol pairs a specialized ultrasound scan with a maternal blood sample:
- Nuchal Translucency (NT) Scan: Measures the fluid-filled space behind the fetal neck. Increased thickness can indicate a higher risk for Down syndrome, Turner syndrome, or congenital heart defects.
- Nasal Bone & Marker Evaluation: Checks for nasal bone presence, ductus venosus blood flow, and tricuspid valve regurgitation.
- Double Marker Blood Test: Measures free Beta-hCG (Human Chorionic Gonadotropin) and PAPP-A (Pregnancy-Associated Plasma Protein A). Algorithms combine these biomarker levels with the NT measurement and maternal age to calculate a personalized risk score.
C. Non-Invasive Prenatal Testing / Cell-Free DNA (NIPT / cfDNA)
- Screening Window: Available from 10 weeks of gestation onward.
- Clinical Methodology: Analyzes tiny fragments of cell-free fetal DNA circulating in maternal blood.
- Accuracy: Offers over 99% detection sensitivity for Trisomy 21 (Down Syndrome), Trisomy 18 (Edwards Syndrome), and Trisomy 13 (Patau Syndrome), making it the most accurate non-invasive screening option.
2. Second Trimester Screening Protocols
A. Target Scan for Fetal Anomalies (TIFFA / Anomaly Scan)
- Screening Window: Performed between 18 and 22 weeks.
- Clinical Methodology: A detailed organ-by-organ ultrasound exam evaluating:
- Brain & Spine: Ventricles, cerebellum, cisterna magna, and neural tube closure.
- Facial Profile: Upper lip continuity, palate, orbits, and nasal bridge.
- Cardiovascular System: Four-chamber heart view, left/right outflow tracts, and three-vessel trachea view.
- Gastrointestinal & Abdomen: Stomach bubble, kidneys, urinary bladder, and abdominal wall closure.
- Musculoskeletal: Long bones (femur, humerus), hands, feet, and spine alignment.
- Placental & Fluid Audit: Placental location relative to the cervix and Amniotic Fluid Index (AFI).
B. Fetal Echocardiography
- Screening Window: Performed between 18 and 24 weeks.
- Clinical Methodology: A targeted high-resolution ultrasound of the fetal heart. Strongly recommended for pregnancies with high NT readings, maternal diabetes, IVF conception, or a family history of congenital heart disease.
C. Second Trimester Quadruple Marker Test
- Screening Window: Performed between 15 and 20+6 weeks (best at 16–18 weeks) for patients who missed first-trimester screening.
- Biomarkers Tested: Alpha-Fetoprotein (AFP), Unconjugated Estriol (uE3), Total hCG, and Inhibin-A. Screen for neural tube defects (spina bifida) alongside chromosomal variations.
3. Third Trimester Screening Protocols
A. Growth & Color Doppler Scan
- Screening Window: Performed between 28 and 36 weeks.
- Clinical Methodology: Tracks fetal weight progression against standardized growth percentiles. Color Doppler ultrasound measures blood flow in the Umbilical Artery, Middle Cerebral Artery (MCA), and Uterine Arteries to confirm adequate oxygenation and rule out placental insufficiency or Fetal Growth Restriction (FGR).
B. Biophysical Profile (BPP) & Non-Stress Test (NST)
- Screening Window: Late third trimester (36 weeks onward) or during high-risk pregnancy monitoring.
- Clinical Methodology: Combines cardiotocography (CTG) recording of fetal heart rate responses with ultrasound assessments of fetal breathing, body movements, muscle tone, and amniotic fluid volume.
Essential Maternal Blood & Metabolic Panels
In addition to fetal imaging, comprehensive Pregnancy Screening in Vizag includes crucial maternal blood tests:
| Test Panel | Gestational Timing | Medical Objective |
| Complete Blood Count (CBC) | 1st & 3rd Trimester | Identifies maternal anemia and tracks baseline platelet levels. |
| Blood Grouping & Rh Factor | First Visit | Screens for Rh incompatibility to evaluate the need for Anti-D immunoglobulin. |
| Infectious Disease Screen (TORCH/TRID) | First Visit | Screens for Hepatitis B, HIV, Syphilis, Rubella, and Toxoplasmosis. |
| Thyroid Profile (TSH, FT4) | Trimester-wise | Identifies hypothyroidism to support healthy fetal brain development. |
| 75g OGTT (GDM Screen) | 24 to 28 Weeks | Diagnoses Gestational Diabetes Mellitus to prevent fetal macrosomia. |
| Preeclampsia Screening (sFlt-1/PlGF) | 1st & 2nd Trimester | Evaluates placental biomarkers to predict early-onset preeclampsia risk. |
Patient Journey: What to Expect During Screening
1.1. Baseline & First Trimester Combined Screening:First Trimester (Weeks 6–13).
Undergo an early dating scan, baseline maternal blood panel, and the First Trimester Combined Screening (NT ultrasound + Double Marker blood test) between 11 and 13+6 weeks.
2.2. Anomaly Scan & Diabetes Screening:Mid-Pregnancy (Weeks 18–24).
Complete the detailed Anomaly Scan (TIFFA) to verify organ anatomy, get a Fetal Echo if indicated, and take the 75g Oral Glucose Tolerance Test (OGTT) for gestational diabetes.
3.3. Fetal Growth & Doppler Evaluation:Third Trimester (Weeks 28–36).
Perform growth scans and color Doppler imaging to track weight progression, placental location, and umbilical blood flow as you approach delivery.
4.4. Final Well-being & BPP Assessment:Pre-Delivery Phase (Weeks 36+).
Review final blood panels, confirm fetal positioning (cephalic), and perform Non-Stress Tests (NST) or Biophysical Profiles as recommended by your obstetrician.
Comparative Matrix: Screening vs. Diagnostic Tests
It is vital to understand the difference between screening and diagnostic procedures:
| Parameter | Prenatal Screening Tests | Invasive Diagnostic Tests |
| Primary Examples | NT Scan, Double Marker, Quad Marker, NIPT, Anomaly Scan. | Chorionic Villus Sampling (CVS), Amniocentesis. |
| Procedure Nature | Completely non-invasive (ultrasound & maternal blood draws). | Invasive sampling of placental tissue or amniotic fluid under ultrasound guidance. |
| Risk to Pregnancy | Zero risk of miscarriage. | Small procedural risk of pregnancy loss (~0.2% to 0.5%). |
| Primary Outcome | Calculates a statistical risk probability (e.g., 1 in 5,000). | Delivers a definitive diagnostic answer via fetal karyotyping or chromosomal microarray. |
| Who Should Get It | Offered to all pregnant women as routine care. | Offered when screening tests show high-risk results or structural anomalies are detected. |
Cost Guidelines for Pregnancy Screening in Visakhapatnam
Screening costs depend on the medical center, equipment technology (3D/4D HD-Live systems), and laboratory processing standards:
| Screening Procedure | Indicative Price Range (INR) | Primary Coverage Scope |
| Early Viability / Dating Ultrasound | ₹1,200 – ₹2,200 | Sac confirmation, heart rate check, and accurate due date calculation. |
| NT Scan (First Trimester) | ₹1,800 – ₹3,200 | Nuchal translucency measurement and early anatomical audit. |
| Double Marker Blood Panel | ₹2,000 – ₹3,500 | Biochemical testing for free Beta-hCG and PAPP-A. |
| Target Anomaly Scan (TIFFA) | ₹2,500 – ₹4,500 | Comprehensive organ-by-organ structural examination. |
| Fetal Echocardiogram | ₹3,000 – ₹5,500 | Targeted high-resolution ultrasound of the fetal heart. |
| Non-Invasive Prenatal Test (NIPT) | ₹12,000 – ₹25,000 | Cell-free DNA screening for major trisomies and chromosomal variations. |
| Growth Scan with Color Doppler | ₹2,200 – ₹4,000 | Fetal weight tracking and umbilical blood flow assessment. |
Top Healthcare Hubs for Pregnancy Screening in Vizag
Visakhapatnam is home to renowned fetal medicine centers, diagnostic chains, and tertiary maternity hospitals:
- Health City, Arilova: Major medical district featuring specialized fetal medicine units equipped with advanced ultrasound platforms and genetic counseling services.
- MVP Colony & Siripuram: Key centers for boutique maternal health clinics, FMF-certified fetal medicine consultants, and advanced diagnostic imaging facilities.
- Maharani Peta: Traditional healthcare hub anchored by King George Hospital (KGH) and long-standing maternity practices offering comprehensive antenatal care.
- Gajuwaka & Sheela Nagar: Accessible healthcare centers serving industrial and suburban communities with complete diagnostic ultrasound and lab services.
Frequently Asked Questions (FAQs)
1. What is pregnancy screening?
Pregnancy screening comprises non-invasive ultrasound scans and maternal blood tests performed at specific gestational weeks to evaluate fetal growth, detect structural anomalies, and estimate chromosomal risk.
2. Why is pregnancy screening essential during antenatal care in Vizag?
Screening helps catch early fetal growth restrictions, chromosomal trisomies (like Down syndrome), structural heart defects, and maternal risks like preeclampsia, enabling timely medical care.
3. When should I get my first pregnancy screening scan in Vizag?
The first essential scan is the Early Pregnancy / Viability Scan performed between 6 and 9 weeks, followed by the First Trimester Combined Screening (NT Scan + Double Marker) between 11 and 13+6 weeks.
4. What is an NT scan, and when is it performed?
The Nuchal Translucency (NT) scan is a specialized ultrasound done between 11.0 and 13.6 weeks to measure fluid thickness at the back of the baby’s neck, assessing trisomy risk.
5. What is the difference between an NT scan and an Anomaly Scan?
The NT scan (11-13+6 weeks) focuses on chromosomal risk markers and early anatomy, whereas the Anomaly Scan (18-22 weeks) is a detailed organ-by-organ structural assessment of the entire baby.
6. What is Non-Invasive Prenatal Testing (NIPT)?
NIPT is a screening blood test that analyzes cell-free fetal DNA circulating in maternal blood, offering over 99% accuracy for Down, Edwards, and Patau syndromes.
7. Is NIPT mandatory for all pregnant women in Visakhapatnam?
No. NIPT is optional but strongly recommended for advanced maternal age (35+ years), high-risk combined biochemical screenings, or previous chromosomal pregnancies.
8. What is a Fetal Echocardiogram, and who needs it?
A Fetal Echo is a targeted ultrasound of the baby’s heart done between 18 and 24 weeks, recommended for high-risk cases like maternal diabetes, high NT measurements, or family history of heart defects.
9. How much does pregnancy screening cost in Vizag?
Individual scans (like NT or Anomaly scans) range from ₹1,800 to ₹3,500. Combined biochemical panels cost ₹2,000 to ₹4,500, while advanced NIPT testing costs ₹12,000 to ₹25,000.
10. Are pregnancy screening scans completely safe for the baby?
Yes. Diagnostic pregnancy ultrasounds use high-frequency sound waves—not ionizing radiation—making them entirely safe for both mother and fetus.
11. What is a Gestational Diabetes Mellitus (GDM) screening test?
It is an Oral Glucose Tolerance Test (OGTT) usually performed between 24 and 28 weeks to measure how effectively maternal metabolism processes sugar during pregnancy.
12. What happens if a pregnancy screening test shows a high-risk result?
A high-risk screening is not a final diagnosis. Your doctor will refer you to a fetal medicine specialist for counseling and invasive diagnostic options like Chorionic Villus Sampling (CVS) or Amniocentesis.
13. What preparation is needed before an ultrasound scan in Vizag?
Early scans (before 12 weeks) require a full bladder for better clarity. Second and third-trimester scans generally do not require full bladder preparation.
14. Which areas in Vizag have top centers for pregnancy screening?
Leading hubs for advanced fetal medicine and ultrasound centers include Health City (Arilova), MVP Colony, Maharani Peta, Siripuram, and Gajuwaka.
15. What is a Third-Trimester Growth Doppler scan?
Performed between 28 and 36 weeks, this scan measures blood flow in the umbilical cord and fetal arteries to confirm adequate oxygenation and placental function.